Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal bupivacaine with or without dexmedetomidine or magnesium for postoperative analgesia after laparoscopic cholecystectomy
PACTR202503801330096Phase 3Recruiting
- Sponsor
- Al-Azhar University
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative pain comparing Intraperitoneal bupivacaine alone, Intraperitoneal bupivacaine + magnesium sulfate and Intraperitoneal bupivacaine + dexmedetomidine (3 arms). Primary endpoint: Duration of analgesia. Started Feb 2025; status: recruiting.
02
Drugs
bupivacainedexmedetomidinemagnesium sulfate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202503801330096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202503801330096.